First reported allergen immunotherapy anaphylaxis treated with neffy nasal spray: A case series.

The neffy intranasal epinephrine delivery system was recently approved by the US Food and Drug Administration; however, published information on its real-world use is limited. Immunotherapy patients reacting in our clinic experienced prompt symptom resolution with neffy, highlighting its viability as an alternative to intramuscular injection in managing anaphylactic reactions.